speb/financial-data huggingface dataset:
Financial ratios for CMC — quarterly report dated 2024-08-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 52.21
Shares outstanding: 110624335
Market cap (USD): 5775696530.35
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMC — quarterly report dated 2024-11-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 60.3
Shares outstanding: 110624335
Market cap (USD): 6670647400.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMC — quarterly report dated 2025-02-28
Total revenue: 1754376000
Gross profit: 219547000
Operating income: 51987000
Net income: 25473000
Capital expenditures: 25103000
Operating cash flow: 32441000
Depreciation & amortization: 70584000
Net tangible assets: 3407643000
Owner earnings: 70954000
Return on net tangible assets (%): 2.0822016860334256
Capex to operating income (%): 48.28707176794199
Buffett classification: The Good
Stock price: 47.51
P/E ratio: 51.581695872590586
Shares outstanding: 110624335
Book value: 4012174000
P/B ratio: 1.3099536948920958
Market cap (USD): 5255762155.849999
Debt to equity: 0.29778618773762056
Current ratio: 2.820329863036424
Quick ratio: 1.9383037289688196
Effective tax rate (%): 29.437673130193904
Interest coverage ratio: 4.655413271245634
COGS to revenue (%): 87.48574991905954
SG&A to revenue (%): 9.550974249533738
Free cash flow (dilution-adjusted): -61864000
Buyback yield (%): 0.9135877647460724
Retained earnings: 4312659000
Inventory turnover: 1.5689072340303738
Receivables turnover: 1.6122689982272518
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.9315693360353211
FCF margin (%): -3.5262680292024053
Rule of 40 score: -3.5262680292024053
Financial ratios for CMC — quarterly report dated 2025-05-31
Total revenue: 2019984000
Gross profit: 299921000
Operating income: 124152000
Net income: 83126000
Capital expenditures: 24831000
Operating cash flow: 154400000
Depreciation & amortization: 72376000
Net tangible assets: 3494494000
Owner earnings: 130671000
Return on net tangible assets (%): 3.739339658331078
Capex to operating income (%): 20.000483278561763
Buffett classification: The Great
Stock price: 45.88
P/E ratio: 46.73564664315509
Shares outstanding: 110624335
Book value: 4097762000
P/B ratio: 1.2385893787389313
Market cap (USD): 5075444489.8
Debt to equity: 0.3280397934287057
Current ratio: 2.857464080802031
Quick ratio: 2.002200922907294
Effective tax rate (%): 24.0941631967273
Interest coverage ratio: 11.427835051546392
COGS to revenue (%): 85.15230813709415
SG&A to revenue (%): 8.701504566372803
Free cash flow (dilution-adjusted): 55404000
Buyback yield (%): 0.9934302325900692
Retained earnings: 4375466000
Inventory turnover: 1.7110117478538531
Receivables turnover: 1.7473985614124627
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.133779916049187
FCF margin (%): 2.7427940023287314
Revenue growth (%): 15.139741993734523
Rule of 40 score: 17.882535996063254
Financial ratios for CMC — annual report dated 2025-08-31
Total revenue: 7798480000
Gross profit: 1220156000
Operating income: 519922000
Net income: 84662000
Capital expenditures: 5758000
Operating cash flow: 715070000
Depreciation & amortization: 285877000
Net tangible assets: 3595405000
Owner earnings: 364781000
Return on net tangible assets (%): 10.145755485126154
Capex to operating income (%): 1.1074738133796993
Buffett classification: The Great
Stock price: 56.99
P/E ratio: 74.46647671505517
Shares outstanding: 110624335
Book value: 4193326000
P/B ratio: 1.503455932510375
Market cap (USD): 6304480851.650001
Debt to equity: 0.32296439628113816
Current ratio: 2.776280511879048
Quick ratio: 2.0340654251266868
Effective tax rate (%): 21.277604723604075
Interest coverage ratio: 11.42735944437118
COGS to revenue (%): 84.35392538033054
SG&A to revenue (%): 8.97910874939732
Free cash flow (dilution-adjusted): 275196000
Buyback yield (%): 3.153661731686671
Retained earnings: 4507114000
Inventory turnover: 7.0408365531782815
Receivables turnover: 6.489647826376406
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.792831955103829
FCF margin (%): 3.5288415178342447
Revenue growth (%): -1.6085345746868647
Rule of 40 score: 1.92030694314738
Financial ratios for CMC — quarterly report dated 2025-08-31
Total revenue: 2114518000
Gross profit: 392808000
Operating income: 213761000
Net income: 151781000
Capital expenditures: 319000
Operating cash flow: 315205000
Depreciation & amortization: 72480000
Net tangible assets: 3595405000
Owner earnings: 223942000
Return on net tangible assets (%): 6.228561177391699
Capex to operating income (%): 0.14923208630199147
Buffett classification: The Great
Stock price: 56.99
P/E ratio: 24.21261560661341
Shares outstanding: 110624335
Book value: 4193326000
P/B ratio: 1.503455932510375
Market cap (USD): 6304480851.650001
Debt to equity: 0.32296439628113816
Current ratio: 2.776280511879048
Quick ratio: 2.0340654251266868
Effective tax rate (%): 21.451822411285857
Interest coverage ratio: 17.600741045697816
COGS to revenue (%): 81.42328417161735
SG&A to revenue (%): 8.467508907467328
Free cash flow (dilution-adjusted): 197051000
Buyback yield (%): 0.7925791381684099
Retained earnings: 4507114000
Inventory turnover: 1.8427609679870707
Receivables turnover: 1.759634844550962
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.615089477950442
FCF margin (%): 9.318955903898667
Revenue growth (%): 4.679938058915318
Rule of 40 score: 13.998893962813984
Financial ratios for CMC — quarterly report dated 2025-11-30
Total revenue: 2120307000
Gross profit: 407138000
Operating income: 211518000
Net income: 177282000
Capital expenditures: 324000
Operating cash flow: 204187000
Depreciation & amortization: 72722000
Net tangible assets: 3721789000
Owner earnings: 249680000
Return on net tangible assets (%): 6.708601696657173
Capex to operating income (%): 0.15317845289762574
Buffett classification: The Great
Stock price: 63.22
P/E ratio: 15.979615453706286
Shares outstanding: 110624335
Book value: 4312489000
P/B ratio: 1.621724822648823
Market cap (USD): 6993670458.7
Debt to equity: 0.7771746200396106
Current ratio: 4.473108349577648
Quick ratio: 3.700625406107862
Effective tax rate (%): 3.0901686391341188
Interest coverage ratio: 8.512475853187379
COGS to revenue (%): 80.79815800259114
SG&A to revenue (%): 9.226022458068572
Free cash flow (dilution-adjusted): 67514000
Buyback yield (%): 0.5562172285599918
Retained earnings: 4664396000
Inventory turnover: 1.801286115483329
Receivables turnover: 1.767296577775629
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.6401167993124046
FCF margin (%): 3.1841615388714937
Revenue growth (%): 0.27377397591318686
Rule of 40 score: 3.4579355147846806
Financial ratios for CSIQ — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 219029921.25984251
Buffett classification: The Gruesome
Stock price: 31.29
Shares outstanding: 67896749
Market cap (USD): 2124489276.21
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CSIQ — annual report dated 2022-12-31
Total revenue: 5491625000
Gross profit: 928776470.5882353
Operating income: 261809558.8235294
Net income: 219525735.29411763
Capital expenditures: 461762499.99999994
Operating cash flow: 673993382.3529412
Depreciation & amortization: 172469852.94117644
Net tangible assets: 1414786029.4117646
Owner earnings: -69766911.76470584
Return on net tangible assets (%): -4.931269486292094
Capex to operating income (%): 176.3734303953536
Buffett classification: The Gruesome
Stock price: 30.9
P/E ratio: 9.557009529152083
Shares outstanding: 67896749
Book value: 1696098529.411765
P/B ratio: 1.2369620677801214
Market cap (USD): 2098009544.1
Debt to equity: 1.753054371321033
Current ratio: 1.0733801148862243
Quick ratio: 0.783560332001716
Effective tax rate (%): 20.577723666640484
Interest coverage ratio: 4.794401206474026
COGS to revenue (%): 83.08740180569075
R&D to revenue (%): 0.9348727541001606
SG&A to revenue (%): 12.064560875450718
Free cash flow (dilution-adjusted): 205341176.4705882
Buyback yield (%): 0
Retained earnings: 937882352.9411764
Inventory turnover: 4.07157952752289
Receivables turnover: 6.042041667913862
Capitalized R&D asset: 51339705.88235294
ROCI (R&D-adjusted, %): 10.462317010993761
FCF margin (%): 3.739169671464971
Rule of 40 score: 3.739169671464971
Financial ratios for CSIQ — annual report dated 2023-12-31
Total revenue: 5767898484.848485
Gross profit: 969684090.9090909
Operating income: 343424242.42424244
Net income: 275480303.030303
Capital expenditures: 1155651515.151515
Operating cash flow: 518647727.27272725
Depreciation & amortization: 232606060.6060606
Net tangible assets: 1923875757.5757575
Owner earnings: -647565151.5151514
Return on net tangible assets (%): -33.659405965546185
Capex to operating income (%): 336.5084267184328
Buffett classification: The Gruesome
Stock price: 26.23
P/E ratio: 6.464824187717321
Shares outstanding: 67896749
Book value: 2807003030.303031
P/B ratio: 0.6344602079313534
Market cap (USD): 1780931726.27
Debt to equity: 1.207891032277496
Current ratio: 1.0394008516826385
Quick ratio: 0.838247654360018
Effective tax rate (%): 14.5648369132856
Interest coverage ratio: 3.973040955661312
COGS to revenue (%): 83.18826010103464
R&D to revenue (%): 1.3245200118839564
SG&A to revenue (%): 10.640895678353521
Free cash flow (dilution-adjusted): -678924242.4242424
Buyback yield (%): 0
Retained earnings: 1174020454.5454545
Inventory turnover: 5.369127556604085
Receivables turnover: 6.293828950555388
Capitalized R&D asset: 110794572.63814616
ROCI (R&D-adjusted, %): 8.060710066147593
Rosenberg metric: 0.7968027790146893
FCF margin (%): -11.770738410318552
Revenue growth (%): 5.030814828916486
Rule of 40 score: -6.739923581402066
Financial ratios for CSIQ — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 16.76
Shares outstanding: 67896749
Market cap (USD): 1137949513.24
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CSIQ — annual report dated 2024-12-31
Total revenue: 4191195104.895105
Gross profit: 698824475.5244756
Operating income: -21035664.335664336
Net income: 25210489.510489512
Capital expenditures: 1307979720.2797203
Operating cash flow: -619107692.3076923
Depreciation & amortization: 350659440.55944055
Net tangible assets: 1947184615.3846154
Owner earnings: -932109790.2097902
Return on net tangible assets (%): -47.86961558987443
Buffett classification: The Gruesome
Stock price: 11.12
P/E ratio: 29.948321652614347
Shares outstanding: 67896749
Book value: 2901960139.86014
P/B ratio: 0.2601730597569089
Market cap (USD): 755011848.88
Debt to equity: 1.4244040018285207
Current ratio: 1.091931218639911
Quick ratio: 0.869267435702014
Interest coverage ratio: -0.21882183489975846
COGS to revenue (%): 83.32636734786496
R&D to revenue (%): 2.0154139322045266
SG&A to revenue (%): 16.73756955348784
Free cash flow (dilution-adjusted): -1942055244.7552447
Buyback yield (%): 0
Retained earnings: 1108921678.3216784
Inventory turnover: 4.138994443040126
Receivables turnover: 4.0274713533476865
Capitalized R&D asset: 152598002.70807624
ROCI (R&D-adjusted, %): -0.12562865287304326
Rosenberg metric: -3.5454235483290253
FCF margin (%): -46.33655070094499
Revenue growth (%): -27.335837898242726
Rule of 40 score: -73.67238859918771
Financial ratios for CSIQ — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.12
Shares outstanding: 67896749
Market cap (USD): 755011848.88
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CSIQ — quarterly report dated 2025-03-31
Total revenue: 836800699.3006994
Gross profit: 98247552.44755246
Operating income: -38325174.82517482
Net income: -23755944.055944055
Capital expenditures: 269291608.3916084
Operating cash flow: -184757342.65734267
Net tangible assets: 1913486713.2867134
Owner earnings: -293047552.44755244
Return on net tangible assets (%): -15.314846474381696
Buffett classification: The Gruesome
Stock price: 8.65
Shares outstanding: 67896749
Book value: 2846609090.909091
P/B ratio: 0.20631806479000533
Market cap (USD): 587306878.85
Debt to equity: 1.5933021524075632
Current ratio: 1.0724561865221525
Quick ratio: 0.8041143223390104
Interest coverage ratio: -1.3536443796774271
COGS to revenue (%): 88.25914551342318
R&D to revenue (%): 2.029374281834326
SG&A to revenue (%): 16.41433197534733
Free cash flow (dilution-adjusted): -454048951.0489511
Buyback yield (%): 2.548553866275249
Retained earnings: 1085165734.2657342
Inventory turnover: 0.7046261374531058
Receivables turnover: 0.8957813219348053
Capitalized R&D asset: 16981818.181818184
ROCI (R&D-adjusted, %): -0.46333914552049627
FCF margin (%): -54.26010654967095
Rule of 40 score: -54.26010654967095
Financial ratios for CSIQ — quarterly report dated 2025-06-30
Total revenue: 1236402189.7810218
Gross profit: 368635036.49635035
Operating income: 93016788.32116787
Net income: 32678832.11678832
Capital expenditures: 286440875.9124087
Operating cash flow: 137632116.78832117
Net tangible assets: 2060283941.6058393
Owner earnings: -253762043.79562038
Return on net tangible assets (%): -12.316848113558155
Capex to operating income (%): 307.9453516749978
Buffett classification: The Gruesome
Stock price: 11.04
P/E ratio: 84.00644542985293
Shares outstanding: 67896749
Book value: 3048072992.7007303
P/B ratio: 0.24591934338679933
Market cap (USD): 749580108.9599999
Debt to equity: 1.7063117537465333
Current ratio: 1.0940965846201662
Quick ratio: 0.8742200331879028
Effective tax rate (%): 42.28929918406587
Interest coverage ratio: 2.8440422255451154
COGS to revenue (%): 70.18486059446086
R&D to revenue (%): 1.4593201017078632
SG&A to revenue (%): 21.380022445628978
Free cash flow (dilution-adjusted): -148808759.12408757
Buyback yield (%): 2.358595409945578
Retained earnings: 1137944525.547445
Inventory turnover: 0.9526557327655633
Receivables turnover: 1.27602221381855
Capitalized R&D asset: 29420883.87524884
ROCI (R&D-adjusted, %): 1.4837323318745332
Rosenberg metric: 15.922175184886385
FCF margin (%): -12.035627270317514
Revenue growth (%): 47.75348429013777
Rule of 40 score: 35.71785701982026
Financial ratios for CSIQ — quarterly report dated 2025-09-30
Total revenue: 1070073381.2949641
Gross profit: 184389208.63309354
Operating income: 24884172.661870506
Net income: 6464748.20143885
Capital expenditures: 211836690.64748204
Operating cash flow: -80618705.03597122
Net tangible assets: 2040479136.6906476
Owner earnings: -205371942.4460432
Return on net tangible assets (%): -10.064888131085025
Capex to operating income (%): 851.2908728208391
Buffett classification: The Gruesome
Stock price: 13.04
P/E ratio: 57.53798646320706
Shares outstanding: 67896749
Book value: 3136046762.5899277
P/B ratio: 0.2823215576762661
Market cap (USD): 885373606.9599999
Debt to equity: 1.697369299431879
Current ratio: 1.0699190405641659
Quick ratio: 0.8614135579827263
Interest coverage ratio: 0.778785968388346
COGS to revenue (%): 82.7685454234968
R&D to revenue (%): 1.3445591709571456
SG&A to revenue (%): 14.645469079643567
Free cash flow (dilution-adjusted): -292455395.68345326
Buyback yield (%): 0
Retained earnings: 1128035971.2230217
Inventory turnover: 0.9893153069317911
Receivables turnover: 1.1362392928650165
Capitalized R&D asset: 32080623.798771203
ROCI (R&D-adjusted, %): 0.34324743275873937
Rosenberg metric: -10.211448042908769
FCF margin (%): -27.330405633446773
Revenue growth (%): -13.452645899593248
Rule of 40 score: -40.78305153304002
Financial ratios for CSIQ — annual report dated 2025-12-31
Total revenue: 4084019708.0291967
Gross profit: 749070072.9927007
Operating income: 31500729.927007295
Net income: -76004379.56204379
Capital expenditures: 948436496.3503649
Operating cash flow: -184482481.7518248
Depreciation & amortization: 405148175.1824817
Net tangible assets: 2026270072.9927006
Owner earnings: -619292700.7299271
Return on net tangible assets (%): -30.563186466810045
Capex to operating income (%): 3010.8397441838915
Buffett classification: The Gruesome
Stock price: 23.77
Shares outstanding: 67896749
Book value: 3116516788.321168
P/B ratio: 0.5178556168148841
Market cap (USD): 1613905723.73
Debt to equity: 1.7986517794992911
Current ratio: 1.0219604200677936
Quick ratio: 0.8282059534844606
Interest coverage ratio: 0.24222354433505833
COGS to revenue (%): 81.65850983725602
R&D to revenue (%): 1.6207911662815384
SG&A to revenue (%): 17.236453208133465
Free cash flow (dilution-adjusted): -1217955474.4525547
Buyback yield (%): 0
Retained earnings: 1081483211.678832
Inventory turnover: 4.030634146685734
Receivables turnover: 4.211407087372795
Capitalized R&D asset: 147999283.80378747
ROCI (R&D-adjusted, %): 0.31656659295084844
Rosenberg metric: 0.5948341312302298
FCF margin (%): -29.822468095784405
Revenue growth (%): -2.5571559944974327
Rule of 40 score: -32.37962409028184
Financial ratios for CSIQ — quarterly report dated 2025-12-31
Total revenue: 888473722.6277372
Gross profit: 90803649.63503648
Operating income: -46759854.01459853
Net income: -43807299.27007299
Capital expenditures: 165981021.89781022
Operating cash flow: -47470072.992700726
Net tangible assets: 2026270072.9927006
Owner earnings: -209788321.16788322
Return on net tangible assets (%): -10.353423463341008
Buffett classification: The Gruesome
Stock price: 23.77
Shares outstanding: 67896749
Book value: 3116516788.321168
P/B ratio: 0.5178556168148841
Market cap (USD): 1613905723.73
Debt to equity: 1.7986517794992911
Current ratio: 1.0219604200677936
Quick ratio: 0.8282059534844606
Interest coverage ratio: -1.3219901770605471
COGS to revenue (%): 89.77981595601085
R&D to revenue (%): 1.7813703316357337
SG&A to revenue (%): 15.444594970954043
Free cash flow (dilution-adjusted): -280668613.1386861
Buyback yield (%): 0
Retained earnings: 1081483211.678832
Inventory turnover: 0.9640674030624443
Receivables turnover: 0.9161866983802012
Capitalized R&D asset: 31421024.733497873
ROCI (R&D-adjusted, %): -0.6878800454367759
Rosenberg metric: -6.5045215764437865
FCF margin (%): -31.589973455667845
Revenue growth (%): -16.970766850350167
Rule of 40 score: -48.56074030601801
Financial ratios for CUPR — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 5995112.5
Buffett classification: The Gruesome
Stock price: 46.88
Shares outstanding: 920625
Book value: 5995112.5
P/B ratio: 7.199014196981292
Market cap (USD): 43158900
Debt to equity: 0.02670717188376365
Current ratio: 3.584319699481103
Quick ratio: 3.584319699481103
Buyback yield (%): 0
Retained earnings: -5106364.84375
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DRT.TO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.905511811023622
Shares outstanding: 193680944
Market cap (USD): 369061326.36220473
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DRT.TO — annual report dated 2022-12-31
Total revenue: 126588970.58823529
Gross profit: 20705882.352941174
Operating income: -27806617.647058822
Net income: -40413970.58823529
Capital expenditures: 1593382.3529411764
Operating cash flow: -32544117.647058822
Depreciation & amortization: 11116911.764705881
Net tangible assets: 9989705.88235294
Owner earnings: -30890441.176470585
Return on net tangible assets (%): -309.2227292801413
Buffett classification: The Gruesome
Stock price: 0.44852941176470584
Shares outstanding: 193680944
Book value: 13229411.764705881
P/B ratio: 6.566550457981325
Market cap (USD): 86871599.88235293
Debt to equity: 5.502278790573588
Current ratio: 1.725790321684538
Quick ratio: 1.107672648480471
Interest coverage ratio: -7.328875968992248
COGS to revenue (%): 83.64321768577086
R&D to revenue (%): 4.388334175568217
SG&A to revenue (%): 32.92789888534569
Free cash flow (dilution-adjusted): -38320588.23529412
Buyback yield (%): 0
Retained earnings: -122258823.52941176
Inventory turnover: 6.471664194867646
Receivables turnover: 7.893672627235214
Capitalized R&D asset: 5555147.058823529
ROCI (R&D-adjusted, %): -28.45268061221538
FCF margin (%): -30.271664314217507
Rule of 40 score: -30.271664314217507
Financial ratios for DRT.TO — annual report dated 2023-12-31
Total revenue: 137826515.15151516
Gross profit: 45107575.75757576
Operating income: -3480303.0303030303
Net income: -11048484.848484848
Capital expenditures: 930303.0303030303
Operating cash flow: 11228030.303030303
Depreciation & amortization: 6768181.818181817
Net tangible assets: 3523484.848484848
Owner earnings: -5210606.060606061
Return on net tangible assets (%): -147.88217587615569
Buffett classification: The Gruesome
Stock price: 0.3636363636363636
Shares outstanding: 193680944
Book value: 5379545.454545453
P/B ratio: 13.09207901985636
Market cap (USD): 70429434.18181817
Debt to equity: 12.638783269961982
Current ratio: 1.8823337679269885
Quick ratio: 1.3849116984710206
Interest coverage ratio: -0.93241323320479
COGS to revenue (%): 67.27220759518718
R&D to revenue (%): 3.1990150111855598
SG&A to revenue (%): 27.041021046440683
Free cash flow (dilution-adjusted): 6879545.454545453
Buyback yield (%): 0
Retained earnings: -137012121.21212122
Inventory turnover: 7.290701137785191
Receivables turnover: 11.181304160776843
Capitalized R&D asset: 8131039.438502673
ROCI (R&D-adjusted, %): -3.1176734684379364
Rosenberg metric: 4.392627800172473
FCF margin (%): 4.991452803535405
Revenue growth (%): 8.877190888796314
Rule of 40 score: 13.86864369233172
Financial ratios for DRT.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.5185185185185185
Shares outstanding: 193680944
Market cap (USD): 100427156.14814815
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DRT.TO — annual report dated 2024-12-31
Total revenue: 121897202.7972028
Gross profit: 45017482.51748252
Operating income: 4104195.8041958045
Net income: 10328671.328671329
Capital expenditures: 968531.4685314685
Operating cash flow: 5135664.335664336
Depreciation & amortization: 4597902.097902098
Net tangible assets: 28001398.601398602
Owner earnings: 13958041.958041957
Return on net tangible assets (%): 49.847659957045096
Capex to operating income (%): 23.598568751064917
Buffett classification: The Great
Stock price: 0.7062937062937064
P/E ratio: 13.244262250507788
Shares outstanding: 193680944
Book value: 29783216.78321679
P/B ratio: 4.593044222587462
Market cap (USD): 136795631.77622378
Debt to equity: 1.2285278234327306
Current ratio: 2.2708030431107353
Quick ratio: 1.7599323753169904
Effective tax rate (%): 2.943882244710211
Interest coverage ratio: 1.4690863579474345
COGS to revenue (%): 63.0693063626924
R&D to revenue (%): 3.0187077269050504
SG&A to revenue (%): 26.27801713010504
Free cash flow (dilution-adjusted): 832167.8321678322
Buyback yield (%): 0.01993684075917072
Retained earnings: -116152447.55244756
Inventory turnover: 7.276325368985372
Receivables turnover: 8.755047714716222
Capitalized R&D asset: 8467009.718222953
ROCI (R&D-adjusted, %): 4.592804174589363
Rosenberg metric: -0.020433518371662376
FCF margin (%): 0.6826800066546959
Revenue growth (%): -11.5575093346886
Rule of 40 score: -10.874829328033904
Financial ratios for DRT.TO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.7062937062937064
Shares outstanding: 193680944
Market cap (USD): 136795631.77622378
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DRT.TO — quarterly report dated 2025-03-31
Total revenue: 28877622.377622377
Gross profit: 10169230.76923077
Operating income: -78321.67832167832
Net income: -462237.7622377623
Capital expenditures: 208391.6083916084
Operating cash flow: 2576223.7762237764
Depreciation & amortization: 1034965.034965035
Net tangible assets: 25488111.88811189
Owner earnings: 364335.6643356643
Buffett classification: The Gruesome
Stock price: 0.7062937062937064
Shares outstanding: 193680944
Book value: 27413286.71328672
P/B ratio: 4.990121513226702
Market cap (USD): 136795631.77622378
Debt to equity: 1.3086911048187544
Current ratio: 1.6137925708548921
Quick ratio: 1.2412026668726026
Interest coverage ratio: -0.24833702882483372
COGS to revenue (%): 64.78508293982323
R&D to revenue (%): 2.9737256326431774
SG&A to revenue (%): 27.596561327037172
Free cash flow (dilution-adjusted): 1516083.916083916
Buyback yield (%): 1.7953380704155788
Retained earnings: -116614685.31468531
Inventory turnover: 1.8483487632997098
Receivables turnover: 2.447546230440967
Capitalized R&D asset: 858741.2587412588
ROCI (R&D-adjusted, %): 0.9517652551808354
FCF margin (%): 5.250030270008476
Rule of 40 score: 5.250030270008476
Financial ratios for DRT.TO — quarterly report dated 2025-06-30
Total revenue: 28410218.97810219
Gross profit: 7896350.364963503
Operating income: -3039416.05839416
Net income: -4818978.10218978
Capital expenditures: 367153.2846715328
Operating cash flow: -2862773.722627737
Depreciation & amortization: 1129197.0802919706
Net tangible assets: 22938686.13138686
Owner earnings: -4056934.3065693425
Return on net tangible assets (%): -17.68599249029466
Buffett classification: The Gruesome
Stock price: 0.5985401459854014
Shares outstanding: 193680944
Book value: 25173722.627737224
P/B ratio: 4.605032883321734
Market cap (USD): 115925820.49635035
Debt to equity: 1.5127290651820922
Current ratio: 1.4819444783553481
Quick ratio: 1.0955880557658029
Interest coverage ratio: -8.585567010309278
COGS to revenue (%): 72.20595036226298
R&D to revenue (%): 3.802476748368532
SG&A to revenue (%): 29.880273367247316
Free cash flow (dilution-adjusted): -3992700.729927007
Buyback yield (%): 0.3072692330637919
Retained earnings: -126552554.74452554
Inventory turnover: 1.7760364004044487
Receivables turnover: 2.151218703365943
Capitalized R&D asset: 1655648.614159563
ROCI (R&D-adjusted, %): -5.040783785391216
Rosenberg metric: -2.6467581254903845
FCF margin (%): -14.0537485226864
Revenue growth (%): -1.618566076556168
Rule of 40 score: -15.672314599242569
Financial ratios for DRT.TO — quarterly report dated 2025-09-30
Total revenue: 27133812.94964029
Gross profit: 8249640.287769785
Operating income: -794964.0287769785
Net income: -2506474.820143885
Capital expenditures: 203597.1223021583
Operating cash flow: 3158273.3812949643
Depreciation & amortization: 1103597.1223021583
Net tangible assets: 20389928.05755396
Owner earnings: -1606474.820143885
Return on net tangible assets (%): -7.878766494954484
Buffett classification: The Gruesome
Stock price: 0.5683453237410072
Shares outstanding: 193680944
Book value: 22652517.98561152
P/B ratio: 4.859400570394128
Market cap (USD): 110077658.8201439
Debt to equity: 1.6382951694350045
Current ratio: 1.3944566771843008
Quick ratio: 1.031848001271196
Interest coverage ratio: -2.3763440860215055
COGS to revenue (%): 69.59645773676955
R&D to revenue (%): 2.1343726800296956
SG&A to revenue (%): 26.42379891823099
Free cash flow (dilution-adjusted): 2068345.3237410074
Buyback yield (%): 0.13790133509207633
Retained earnings: -127238129.49640289
Inventory turnover: 1.643232753223989
Receivables turnover: 2.382263769580596
Capitalized R&D asset: 1586316.9264700538
ROCI (R&D-adjusted, %): -2.177418258088415
Rosenberg metric: 0.3270318880031129
FCF margin (%): 7.622759571534628
Revenue growth (%): -4.4927708211109465
Rule of 40 score: 3.1299887504236814
Financial ratios for DRT.TO — annual report dated 2025-12-31
Total revenue: 123251824.81751823
Gross profit: 40472262.773722626
Operating income: -3129927.00729927
Net income: -10545985.401459854
Capital expenditures: 1154014.598540146
Operating cash flow: -140145.98540145985
Depreciation & amortization: 4508029.197080292
Net tangible assets: 18632116.788321167
Owner earnings: -7191970.802919708
Return on net tangible assets (%): -38.599858967327435
Buffett classification: The Gruesome
Stock price: 0.6642335766423357
Shares outstanding: 193680944
Book value: 20828467.15328467
P/B ratio: 6.176613248291573
Market cap (USD): 128649386.16058393
Debt to equity: 1.609181706676012
Current ratio: 1.099388513930252
Quick ratio: 0.8217174476183764
Interest coverage ratio: -2.2857142857142856
COGS to revenue (%): 67.16295046045424
R&D to revenue (%): 2.7159397115868646
SG&A to revenue (%): 27.993248645287377
Free cash flow (dilution-adjusted): -5345985.401459854
Buyback yield (%): 2.489650206361046
Retained earnings: -131809489.05109487
Inventory turnover: 7.19730913244907
Receivables turnover: 7.314489928525016
Capitalized R&D asset: 7267857.84288704
ROCI (R&D-adjusted, %): -8.838999500256705
Rosenberg metric: -1.235207950128591
FCF margin (%): -4.3374492908116435
Revenue growth (%): 1.1112822847699697
Rule of 40 score: -3.226167006041674
Financial ratios for DRT.TO — quarterly report dated 2025-12-31
Total revenue: 37169343.06569343
Gross profit: 13591240.875912407
Operating income: 797810.2189781021
Net income: -2701459.8540145983
Capital expenditures: 362773.7226277372
Operating cash flow: -3170802.919708029
Depreciation & amortization: 1178832.1167883212
Net tangible assets: 18632116.788321167
Owner earnings: -1885401.4598540142
Return on net tangible assets (%): -10.119094256836165
Capex to operating income (%): 45.471180237877405
Buffett classification: The Good
Stock price: 0.6642335766423357
Shares outstanding: 193680944
Book value: 20828467.15328467
P/B ratio: 6.176613248291573
Market cap (USD): 128649386.16058393
Debt to equity: 1.609181706676012
Current ratio: 1.099388513930252
Quick ratio: 0.8217174476183764
Interest coverage ratio: 2.3010526315789472
COGS to revenue (%): 63.43427202387966
R&D to revenue (%): 2.1071442598483956
SG&A to revenue (%): 28.03503397352814
Free cash flow (dilution-adjusted): -5034306.569343065
Buyback yield (%): 0.10439736507986157
Retained earnings: -131809489.05109487
Inventory turnover: 2.0500095195786
Receivables turnover: 2.2058479532163746
Capitalized R&D asset: 1527729.6119308933
ROCI (R&D-adjusted, %): 2.195460411620687
Rosenberg metric: 9.223384866482291
FCF margin (%): -13.544244138093553
Revenue growth (%): 36.98532946578075
Rule of 40 score: 23.441085327687198
Financial ratios for DSM — annual report dated 2021-11-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.71
Shares outstanding: 49428691
Market cap (USD): 331666516.61
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DSM — annual report dated 2022-11-30
Total revenue: -70379252
Net income: -71449435
Capital expenditures: 0
Operating cash flow: 38826932
Net tangible assets: 373963200
Owner earnings: -71449435
Return on net tangible assets (%): -19.106006954695008
Buffett classification: The Gruesome
Stock price: 5.08
Shares outstanding: 49428691
Book value: 373963200
P/B ratio: 0.6714504268869236
Market cap (USD): 251097750.28
Debt to equity: 0.31129980436577714
Free cash flow (dilution-adjusted): 38826932
Buyback yield (%): 0
Retained earnings: -43772951
Receivables turnover: -9.186043904222402
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DSM — annual report dated 2023-11-30
Total revenue: 10058351
Net income: 9091354
Capital expenditures: 0
Operating cash flow: 15704755
Net tangible assets: 319748821
Owner earnings: 9091354
Return on net tangible assets (%): 2.8432799131415716
Buffett classification: The Gruesome
Stock price: 4.85
P/E ratio: 26.368916153743434
Shares outstanding: 49428691
Book value: 319748821
P/B ratio: 0.7497420963125302
Market cap (USD): 239729151.35
Debt to equity: 0.35513813513013703
COGS to revenue (%): 0
SG&A to revenue (%): 12.942419686885057
Free cash flow (dilution-adjusted): 15704755
Buyback yield (%): 20.564874869148866
Retained earnings: -48687330
Receivables turnover: 1.368063217602869
Capitalized R&D asset: 0
FCF margin (%): 156.13647803700624
Rule of 40 score: 156.13647803700624
Financial ratios for DSM — quarterly report dated 2024-11-30
Capital expenditures: 0
Net tangible assets: 341476703
Buffett classification: The Gruesome
Stock price: 5.71
Shares outstanding: 49428691
Book value: 341476703
P/B ratio: 0.8265214672931874
Market cap (USD): 282237825.61
Debt to equity: 0.36716592054011954
Buyback yield (%): 0
Retained earnings: -26959448
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DSM — annual report dated 2024-11-30
Total revenue: 2835715.24
Net income: 32404479
Capital expenditures: 0
Operating cash flow: -1869884
Net tangible assets: 341476703
Owner earnings: 32404479
Return on net tangible assets (%): 9.489513842471414
Buffett classification: The Gruesome
Stock price: 5.71
P/E ratio: 8.70983994558283
Shares outstanding: 49428691
Book value: 341476703
P/B ratio: 0.8265214672931874
Market cap (USD): 282237825.61
Debt to equity: 0.36716592054011954
COGS to revenue (%): 0
SG&A to revenue (%): 48.41187791479373
Free cash flow (dilution-adjusted): -1869884
Buyback yield (%): 0
Retained earnings: -26959448
Receivables turnover: 0.37519555393607223
Capitalized R&D asset: 0
FCF margin (%): -65.94047151222419
Revenue growth (%): -71.80735450572365
Rule of 40 score: -137.74782601794783
Financial ratios for DSM — quarterly report dated 2025-05-31
Capital expenditures: 0
Net tangible assets: 304975944
Buffett classification: The Gruesome
Stock price: 5.26
Shares outstanding: 49428691
Book value: 304975944
P/B ratio: 0.8525095823951281
Market cap (USD): 259994914.66
Debt to equity: 0.4202462604722686
Buyback yield (%): 0
Retained earnings: -63460207
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EML.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.6165413533834583
Shares outstanding: 389474299
Market cap (USD): 1019075609.4135337
Buyback yield (%): 0.04227626131854033
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EML.AX — annual report dated 2022-06-30
Total revenue: 154890344.8275862
Gross profit: 103464827.5862069
Operating income: -2291034.4827586208
Net income: -3311034.4827586208
Capital expenditures: 1161379.3103448276
Depreciation & amortization: 20651034.482758623
Net tangible assets: -7822758.620689656
Owner earnings: 16178620.689655172
Buffett classification: The Gruesome
Stock price: 0.8482758620689655
Shares outstanding: 389474299
Book value: 301460000.00000024
P/B ratio: 1.0959385879981782
Market cap (USD): 330381646.7379311
Debt to equity: 0.20911106179809968
Current ratio: 0.883358197477333
Quick ratio: 0.883358197477333
Interest coverage ratio: -1.4744784731469152
COGS to revenue (%): 33.20124136764163
SG&A to revenue (%): 30.826702761909424
Free cash flow (dilution-adjusted): -38342068.965517245
Buyback yield (%): 0
Retained earnings: -41766896.551724136
Receivables turnover: 5.993408587516345
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.5704336119677724
FCF margin (%): -24.754331206504272
Rule of 40 score: -24.754331206504272
Financial ratios for EML.AX — annual report dated 2023-06-30
Total revenue: 146811920.5298013
Gross profit: 87806622.5165563
Operating income: -48521854.30463576
Net income: -188625165.5629139
Capital expenditures: 289403.9735099338
Depreciation & amortization: 23225827.814569537
Net tangible assets: -11864238.410596026
Owner earnings: -165688741.7218543
Buffett classification: The Gruesome
Stock price: 0.41721854304635764
Shares outstanding: 389474299
Book value: 115598013.24503303
P/B ratio: 1.4056980307986697
Market cap (USD): 162495899.58278146
Debt to equity: 0.5642526911597054
Current ratio: 0.8905311185128711
Quick ratio: 0.8905311185128711
Interest coverage ratio: -20.454494695700728
COGS to revenue (%): 40.19108107864277
SG&A to revenue (%): 37.669496495042544
Free cash flow (dilution-adjusted): -9527152.317880794
Buyback yield (%): 0
Retained earnings: -224904635.7615894
Receivables turnover: 5.2219160012248835
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -25.738504828516522
FCF margin (%): -6.489358822839512
Revenue growth (%): -5.215576417482489
Rule of 40 score: -11.704935240322001
Financial ratios for EML.AX — annual report dated 2024-06-30
Total revenue: 111686000
Gross profit: 77397333.33333333
Operating income: -37119333.333333336
Net income: -17656666.666666668
Capital expenditures: 908666.6666666666
Depreciation & amortization: 16574666.666666666
Net tangible assets: -2958666.6666666665
Owner earnings: -1990666.6666666684
Buffett classification: The Gruesome
Stock price: 0.62
Shares outstanding: 389474299
Book value: 1255414666.6666667
P/B ratio: 0.19234606046235983
Market cap (USD): 241474065.38
Debt to equity: 0.04813071059655189
Current ratio: 1.5483100714855065
Quick ratio: 1.5483100714855065
Effective tax rate (%): 494.86442070665566
Interest coverage ratio: -10.713680969790264
COGS to revenue (%): 30.700953267792443
SG&A to revenue (%): 52.251252022037974
Free cash flow (dilution-adjusted): 3228666.6666666665
Buyback yield (%): 0
Retained earnings: -244060666.66666666
Receivables turnover: 4.893357868909919
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.9137884116218706
FCF margin (%): 2.8908427794590787
Revenue growth (%): -23.925795945616766
Rule of 40 score: -21.03495316615769
Financial ratios for FLGT — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 100.59
Shares outstanding: 28400623
Market cap (USD): 2856818667.57
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FLGT — annual report dated 2022-12-31
Total revenue: 618968000
Gross profit: 366901000
Operating income: 181502000
Net income: 143403000
Capital expenditures: 18363000
Operating cash flow: 253520000
Depreciation & amortization: 32662000
Net tangible assets: 973015000
Owner earnings: 157702000
Return on net tangible assets (%): 16.207561034516427
Capex to operating income (%): 10.1172438871197
Buffett classification: The Great
Stock price: 29.78
P/E ratio: 5.8978581545713835
Shares outstanding: 28400623
Book value: 1269875000
P/B ratio: 0.66602661910818
Market cap (USD): 845770552.94
Debt to equity: 0.03066207303868491
Current ratio: 7.126255575606932
Quick ratio: 7.077678277548889
Effective tax rate (%): 22.87841325906806
Interest coverage ratio: 179.17275419545902
COGS to revenue (%): 40.723753085781496
R&D to revenue (%): 4.670677644078531
SG&A to revenue (%): 24.23259360742397
Free cash flow (dilution-adjusted): 202105000
Buyback yield (%): 8.998303350175751
Retained earnings: 801000000
Inventory turnover: 58.894158878504676
Receivables turnover: 8.240820130475303
Capitalized R&D asset: 28910000
ROCI (R&D-adjusted, %): 15.131659602348208
FCF margin (%): 32.651930309806
Rule of 40 score: 32.651930309806
Financial ratios for FLGT — annual report dated 2023-12-31
Total revenue: 289213000
Gross profit: 104456000
Operating income: -75295000
Net income: -167825000
Capital expenditures: 21432000
Operating cash flow: 27003000
Depreciation & amortization: 26143000
Net tangible assets: 970993000
Owner earnings: -163114000
Return on net tangible assets (%): -16.79867929016996
Buffett classification: The Gruesome
Stock price: 28.91
Shares outstanding: 28400623
Book value: 1133286000
P/B ratio: 0.7244967386255544
Market cap (USD): 821062010.93
Debt to equity: 0.013457326747175912
Current ratio: 6.955065874168014
Quick ratio: 6.875263633624586
Interest coverage ratio: -154.29303278688525
COGS to revenue (%): 63.88267470687694
R&D to revenue (%): 14.328539865082139
SG&A to revenue (%): 45.11069696037177
Free cash flow (dilution-adjusted): -38126000
Buyback yield (%): 3.384884409463857
Retained earnings: 633175000
Inventory turnover: 31.70705337223271
Receivables turnover: 5.03460701540604
Capitalized R&D asset: 60809700
ROCI (R&D-adjusted, %): -4.685150603003123
Rosenberg metric: -9.078000691802144
FCF margin (%): -13.182671594983628
Revenue growth (%): -53.27496736503341
Rule of 40 score: -66.45763896001704
Financial ratios for FLGT — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 21.73
Shares outstanding: 28400623
Market cap (USD): 617145537.79
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FLGT — annual report dated 2024-12-31
Total revenue: 283470000
Gross profit: 107215000
Operating income: -73918000
Net income: -42708000
Capital expenditures: 40002000
Operating cash flow: 21060000
Depreciation & amortization: 24928000
Net tangible assets: 976195000
Owner earnings: -57782000
Return on net tangible assets (%): -5.919104277321641
Buffett classification: The Gruesome
Stock price: 18.47
Shares outstanding: 28400623
Book value: 1129159000
P/B ratio: 0.46455769896887855
Market cap (USD): 524559506.80999994
Debt to equity: 0.007499386711703135
Current ratio: 4.850148836060852
Quick ratio: 4.735140399731135
COGS to revenue (%): 62.17765548382545
R&D to revenue (%): 17.220869933326277
SG&A to revenue (%): 43.86778142307828
Free cash flow (dilution-adjusted): -63736000
Buyback yield (%): 0.595547303869862
Retained earnings: 590467000
Inventory turnover: 21.02278148854962
Receivables turnover: 3.679994807217967
Capitalized R&D asset: 86121100
ROCI (R&D-adjusted, %): -5.256627527669992
Rosenberg metric: 0.06657818532818532
FCF margin (%): -22.484213497019084
Revenue growth (%): -1.9857336980011273
Rule of 40 score: -24.46994719502021
Financial ratios for FLGT — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 18.47
Shares outstanding: 28400623
Market cap (USD): 524559506.80999994
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FLGT — quarterly report dated 2025-03-31
Total revenue: 73463000
Gross profit: 28346000
Operating income: -19795000
Net income: -11530000
Capital expenditures: 4716000
Operating cash flow: -4431000
Depreciation & amortization: 5919000
Net tangible assets: 972114000
Owner earnings: -10327000
Return on net tangible assets (%): -1.0623239661192
Buffett classification: The Gruesome
Stock price: 16.9
Shares outstanding: 28400623
Book value: 1122770000
P/B ratio: 0.42748784586335575
Market cap (USD): 479970528.7
Debt to equity: 0.0068197404633184
Current ratio: 6.323052415990291
Quick ratio: 6.192277933702496
Interest coverage ratio: -1413.9285714285713
COGS to revenue (%): 61.41458965737855
R&D to revenue (%): 16.872439187073766
SG&A to revenue (%): 45.94966173447858
Free cash flow (dilution-adjusted): -19699000
Buyback yield (%): 2.2013851618385836
Retained earnings: 578937000
Inventory turnover: 5.233990719257541
Receivables turnover: 0.9132645450024863
Capitalized R&D asset: 12395000
ROCI (R&D-adjusted, %): -1.000818127956601
FCF margin (%): -26.81485918081211
Rule of 40 score: -26.81485918081211
Financial ratios for FLGT — quarterly report dated 2025-06-30
Total revenue: 81803000
Gross profit: 34435000
Operating income: -19713000
Net income: -18957000
Capital expenditures: 6826000
Operating cash flow: -30171000
Depreciation & amortization: 6054000
Net tangible assets: 963465000
Owner earnings: -19729000
Return on net tangible assets (%): -2.0477132018288158
Buffett classification: The Gruesome
Stock price: 19.88
Shares outstanding: 28400623
Book value: 1111636000
P/B ratio: 0.5079040128603248
Market cap (USD): 564604385.24
Debt to equity: 0.006644261250985035
Current ratio: 6.0100511670288075
Quick ratio: 5.884152239433658
Interest coverage ratio: -1159.5882352941176
COGS to revenue (%): 57.90496681050817
R&D to revenue (%): 16.47861325379265
SG&A to revenue (%): 47.28188452746232
Free cash flow (dilution-adjusted): -47036000
Buyback yield (%): 0.4516436759370998
Retained earnings: 559980000
Inventory turnover: 5.274245629662621
Receivables turnover: 0.9619921208913976
Capitalized R&D asset: 21784650
ROCI (R&D-adjusted, %): -1.2916769122923297
Rosenberg metric: 0.491246470350948
FCF margin (%): -57.49911372443554
Revenue growth (%): 11.352653716837047
Rule of 40 score: -46.14646000759849
Financial ratios for FLGT — quarterly report dated 2025-09-30
Total revenue: 84069000
Gross profit: 35512000
Operating income: -15350000
Net income: -6608000
Capital expenditures: 6047000
Operating cash flow: 11107000
Depreciation & amortization: 6038000
Net tangible assets: 965553000
Owner earnings: -6617000
Return on net tangible assets (%): -0.6853067620317062
Buffett classification: The Gruesome
Stock price: 22.6
Shares outstanding: 28400623
Book value: 1120757000
P/B ratio: 0.5726969180652006
Market cap (USD): 641854079.8000001
Debt to equity: 0.0067302724854718735
Current ratio: 7.005412420953801
Quick ratio: 6.866456797282744
Interest coverage ratio: -548.2142857142857
COGS to revenue (%): 57.75850789232654
R&D to revenue (%): 16.48645755272455
SG&A to revenue (%): 41.605110088141885
Free cash flow (dilution-adjusted): -4660000
Buyback yield (%): 0.055620118533988315
Retained earnings: 553372000
Inventory turnover: 4.824821144674086
Receivables turnover: 1.0680175316013467
Capitalized R&D asset: 26981950
ROCI (R&D-adjusted, %): -1.2603507966404959
Rosenberg metric: 0.07989614243323442
FCF margin (%): -5.54306581498531
Revenue growth (%): 2.7700695573511975
Rule of 40 score: -2.7729962576341123
Financial ratios for FLGT — quarterly report dated 2025-12-31
Total revenue: 83336000
Gross profit: 32582000
Operating income: -36238000
Net income: -23418000
Capital expenditures: 4980000
Operating cash flow: -78143000
Depreciation & amortization: 6112000
Net tangible assets: 953628000
Owner earnings: -22286000
Return on net tangible assets (%): -2.3369699715192924
Buffett classification: The Gruesome
Stock price: 26.27
Shares outstanding: 28400623
Book value: 1106715000
P/B ratio: 0.6741431770690738
Market cap (USD): 746084366.21
Debt to equity: 0.006936745232512436
Current ratio: 6.478868266503466
Quick ratio: 6.35406687302129
Interest coverage ratio: -2264.875
COGS to revenue (%): 60.90285110876452
R&D to revenue (%): 17.00345588941154
SG&A to revenue (%): 63.1467793030623
Free cash flow (dilution-adjusted): -92399000
Buyback yield (%): 0.059912795421608274
Retained earnings: 529954000
Inventory turnover: 4.786307053941909
Receivables turnover: 0.9096823490885274
Capitalized R&D asset: 27904600
ROCI (R&D-adjusted, %): -3.104697606880384
Rosenberg metric: -0.2113997113997114
FCF margin (%): -110.87525199193627
Revenue growth (%): -0.8719028417133545
Rule of 40 score: -111.74715483364962
Financial ratios for FLGT — annual report dated 2025-12-31
Total revenue: 322671000
Gross profit: 130875000
Operating income: -91096000
Net income: -60513000
Capital expenditures: 22569000
Operating cash flow: -101638000
Depreciation & amortization: 24123000
Net tangible assets: 953628000
Owner earnings: -58959000
Return on net tangible assets (%): -6.182599504209189
Buffett classification: The Gruesome
Stock price: 26.27
Shares outstanding: 28400623
Book value: 1106715000
P/B ratio: 0.6741431770690738
Market cap (USD): 746084366.21
Debt to equity: 0.006936745232512436
Current ratio: 6.478868266503466
Quick ratio: 6.35406687302129
Interest coverage ratio: -1214.6133333333332
COGS to revenue (%): 59.44011082495793
R&D to revenue (%): 16.70587068562096
SG&A to revenue (%): 49.59695789209442
Free cash flow (dilution-adjusted): -163794000
Buyback yield (%): 1.8657407433306201
Retained earnings: 529954000
Inventory turnover: 18.08713692946058
Receivables turnover: 3.522224647964196
Capitalized R&D asset: 100286920
ROCI (R&D-adjusted, %): -6.93697514464776
Rosenberg metric: 0.48467715503113734
FCF margin (%): -50.76192158576382
Revenue growth (%): 13.828976611281618
Rule of 40 score: -36.932944974482204
Financial ratios for FPC.V — annual report dated 2021-06-30
Total revenue: 0
Gross profit: -27263.709677419356
Operating income: -4009357.2580645164
Net income: -3104216.935483871
Capital expenditures: 4625508.870967742
Operating cash flow: -2898658.064516129
Depreciation & amortization: 27263.709677419356
Net tangible assets: 32909436.29032258
Owner earnings: -7702462.096774194
Return on net tangible assets (%): -23.40502592880692
Buffett classification: The Gruesome
Stock price: 0.33064516129032256
Shares outstanding: 349918643
Book value: 32909436.29032258
P/B ratio: 3.5156757208645497
Market cap (USD): 115698906.1532258
Debt to equity: 0.6745601522614568
Current ratio: 0.3044294902467039
Quick ratio: 0.3044294902467039
Interest coverage ratio: -13.503369321654105
Free cash flow (dilution-adjusted): -8011549.193548387
Buyback yield (%): 0
Retained earnings: -73756040.32258065
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.28363717558752
Rule of 40 score: 0